FREE! AACE’s Improving Obesity Diagnosis and Treatment through Endocrinology and Primary Care Collaboration is designed to equip primary care physicians, physicians in-training, nurse practitioners, physician assistants, registered dietitians, nurses, and other health care providers with evidence-based knowledge to foster the understanding of obesity as a complex, chronic, progressive, and treatable multi-factorial, neurobehavioral disease, and provides treatment strategies, including information on the safety and effectiveness of anti-obesity medications (AOMs) as adjuncts to lifestyle modifications and bariatric procedures.
This self-paced, online course contains multiple modular activities that allow for high-levels of learner involvement, interactivity, feedback, and focus on case-based approach, including:
- Patient video providing insight into the patient experience.
- Expert presentations
- Self-assessment style patient cases.
- Interactive digital patient simulations.
- A Rapid Recap with additional resources.
- Recognize obesity as a chronic, serious disease warranting diagnosis, long-term management, and early intervention to minimize associated comorbidities and psychosocial health consequences.
- Identify the biological basis of obesity including the role of genetics and hormones on appetite and energy regulation, metabolic adaptation to weight loss, and cardiometabolic risk factors.
- Destigmatize obesity to initiate and enhance patient engagement in healthy weight conversations and facilitate discussions on evidence-based obesity treatments in healthcare settings.
- Manage obesity with shared decision making, including AOM pharmacotherapy, bariatric surgery, behavior, and lifestyle interventions to achieve and maintain clinically meaningful, long-term weight loss.
-
Implement strategies that lead to improved patient adherence in obesity care.
- Primary care physicians (PCPs)
- Physicians in-training
- Nurse practitioners (NPs)
- Physician assistants (PAs)
- Registered dietitians (RDs)
- Nurses
- Other health care providers (HCPs).
- Brandi Addison, DO, FACE, Endocrinology Course Director, South Texas Endocrinology & Metabolism Center, PLLC
- Monica Agarwal, MD, FACE, MEHP, Professor, University of Alabama at Birmingham
- Jaime Almandoz, MD, MBA, FTOS, MRCPI, Medical Director, University of Texas Southwestern Medical Center
- Sandhya Bassin, MD, Endocrinology Fellow, Icahn School of Medicine and Mount Sinai
- Elizabeth Bauer, MD, FACP, Assistant Professor, Naval Medical Center San Diego
- Karla Saint Andre, MD, Endocrinologist, Houston Methodist Hospital
Physicians and Physician Assistants
The American College of Endocrinology (ACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American College of Endocrinology (ACE) designates this enduring activity for a maximum of 3.75 AMA PRA Category 1 Credit(s) TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Only those who receive a passing score will be eligible for MOC credit.
Please allow two weeks for MOC points to appear within your account on the ABIM website. Participation information will be shared.
Nurses
American Association of Clinical Endocrinology is approved by the California Board of Registered Nursing, Provider Number 17762, for 3.75 contact hours.
ABOM:
Applicants for certification through the American Board of Obesity Medicine (ABOM) may claim up to 3.75 Group Two CME credits toward the ABOM application requirement.
This activity is supported by independent educational grants from Lilly USA, LLC and Rhythm Pharmaceuticals.